A Study of YL202 in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Bayer
Convalife (Shanghai) Co., Ltd.
Duke University
Ohio State University Comprehensive Cancer Center
Daiichi Sankyo
ImmunityBio, Inc.
Brigham and Women's Hospital
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
University of Pittsburgh
Weill Medical College of Cornell University
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
Telix Pharmaceuticals (Innovations) Pty Limited
UNICANCER
Centre Hospitalier Universitaire de Besancon
Tasly Biopharmaceuticals Co., Ltd.
Convalife (Shanghai) Co., Ltd.
Charite University, Berlin, Germany
pharmaand GmbH
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Beijing Health Guard Biotechnology, Inc
Seagen Inc.
MultiVir, Inc.
Cambridge University Hospitals NHS Foundation Trust
University of Iowa
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
BIND Therapeutics
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Hoag Memorial Hospital Presbyterian